...
首页> 外文期刊>International heart journal >A case of acute myocardial infarction with repetitive stent thrombosis during emergent percutaneous coronary intervention. Transient decrease in antithrombin III activity and heparin resistance.
【24h】

A case of acute myocardial infarction with repetitive stent thrombosis during emergent percutaneous coronary intervention. Transient decrease in antithrombin III activity and heparin resistance.

机译:一例急诊经皮冠状动脉介入治疗期间发生重复性支架血栓形成的急性心肌梗塞。抗凝血酶III活性和肝素抗性的短暂降低。

获取原文
获取原文并翻译 | 示例
           

摘要

A 59-year-old woman was admitted to our hospital for the treatment of an acute anterior myocardial infarction. She had a history of uncontrolled diabetes mellitus, hypertension, hyperlipidemia, obesity, and smoking. Coronary angiography revealed 90% stenosis with spontaneous dissection in the proximal portion of the left anterior descending artery. At this time, heparin was initiated for the first time. Although direct stenting (Be-stent, 3.0-18 mm) was performed for the culprit lesion, coronary dissection occurred at the left main trunk and additional stenting (Multi Link ZETA stent 3.5-15mm) was performed for the left main trunk. Soon after stenting, repetitive stent thrombosis occurred. Aspiration of the thrombus using an aspiration catheter was ineffective and repetitive angioplasty and intraaortic balloon pumping were required. Although we used 17,000 units of unfractionated heparin during the intervention, the activated coagulation time (ACT) was not prolonged (157 seconds). In the coronary care unit, the ACT and activated partial prothrombin time (aPTT) were not prolonged despite the use of large amounts of heparin (69,000 units in 2 days). Protein-S, protein-C, and hepaplastin testing were within normal limits and heparin-platelet factor IV complex antibody was not detected. In the acute phase, a decrease in the antithrombin III activity (65%) was noted and with administration of argatroban, prolongation of the aPTT was achieved. In the chronic phase, the decrease in antithrombin III activity and heparin resistance had improved spontaneously. It is important to recognize the existence of transient decreases in antithrombin III activity in the acute phase of myocardial infarction.
机译:一名59岁的妇女因急性前壁心肌梗塞入院。她有糖尿病,高血压,高脂血症,肥胖和吸烟史。冠状动脉造影显示左前降支近端有90%的狭窄并自发解剖。这时,肝素首次开始使用。尽管对罪犯病变进行了直接支架置入术(Be-stent,3.0-18 mm),但在左主干处进行了冠状动脉解剖,对左主干进行了额外的置入术(Multi Link ZETA支架3.5-15mm)。支架置入后不久,发生重复性支架血栓形成。使用抽吸导管抽吸血栓无效,需要重复进行血管成形术和主动脉内球囊抽吸术。尽管我们在干预过程中使用了17,000单位普通肝素,但活化凝血时间(ACT)并未延长(157秒)。在冠状动脉护理单元中,尽管使用了大量肝素(2天内为69,000单位),但ACT和活化的部分凝血酶原时间(aPTT)并未延长。蛋白S,蛋白C和肝素检测均在正常范围内,未检测到肝素-血小板因子IV复合抗体。在急性期,抗凝血酶III活性下降(65%),并且使用Argatroban可以延长aPTT。在慢性期,抗凝血酶III活性和肝素抗性的下降自发改善。重要的是要认识到在心肌梗塞急性期抗凝血酶III活性存在瞬时下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号